APA (7th ed.) Citation

Petrakov, A. I., Sheikin, V. V., Krivoshchekov, S. V., Bezverkhniaia, E. A., Guryev, A. M., & Belousov, M. V. (2023). Development of the Tablet Dosage Form Composition for the Inductor of Hepatocytes Monooxygenase System Based on 6,8-dimethyl-2-piperidinomethyl-2,3-dihydrothiazolo[2,3-F]xanthine. LLC Center of Pharmaceutical Analytics (LLC «CPHA»).

Chicago Style (17th ed.) Citation

Petrakov, A. I., V. V. Sheikin, S. V. Krivoshchekov, E. A. Bezverkhniaia, A. M. Guryev, and M. V. Belousov. Development of the Tablet Dosage Form Composition for the Inductor of Hepatocytes Monooxygenase System Based on 6,8-dimethyl-2-piperidinomethyl-2,3-dihydrothiazolo[2,3-F]xanthine. LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2023.

MLA (9th ed.) Citation

Petrakov, A. I., et al. Development of the Tablet Dosage Form Composition for the Inductor of Hepatocytes Monooxygenase System Based on 6,8-dimethyl-2-piperidinomethyl-2,3-dihydrothiazolo[2,3-F]xanthine. LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2023.